FOXP3 and hepatocellular carcinoma: We found that the CD39+Foxp3+/Foxp3+ ratio in tumors was 83.34%, higher than that in peritumoral tissues, and may be characterized as a cell activation marker.[40] In this study, the extensive expression of CD39 in HCC indicated that the tumor escape mechanisms might include both tumor-derived and host-related factors.